Skip to main content
  • Sign in
Menu
  • Membership
  • Events
  • Knowledge Center
  • About
  • Register
  • Sign In
    • Sign In
    • Register
    • Subscribe
taub.png
Stephen Taub
Big Name Hedge Funds Miss Kodiak Sciences’ 178 Percent Stock Rise
Hedge funds were unprepared to take advantage of biotech company Kodiak Sciences’ “eye-popping” clinical trial results.
Stephen Taub September 30, 2026
art-biopharma9.jpg

Andrey Rudakov/Bloomberg

Contact Info

New York
1270 Avenue of the Americas, Suite 1120
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Accessibility Statement and Privacy Policy before using the site.

LinkedIn
X
Bluesky
Instagram

4.32.01 build:2026-11-12   Login